Ferdos Hashi is Head of AAV Delivery at the Kings College London Gene Therapy Vector Facility (GTVF). She is responsible for supporting the establishment of a GMP manufacturing site to allow the manufacture of AAV’s as Investigational Medicinal Products and Specials. Ferdos leads on the AAV facility and equipment design and qualification; manufacturing process, technology transfer, validation works, recruitment and training of personnel, and all other activities required to establish GMP supply of AAV’s.

Ferdos has over 10 years of Industrial GLP and GMP experience in the Bio/Pharmaceutical sector, with previous experience in transitioning companies from process development to GMP manufacture of ATMP’s, including first-in-man clinical trials in the treatment of patients with degenerative diseases.